[1]Tanis,StevenP.;Colca,JerryR.;Parker,TimothyT.;Artman,GeraldD.;Larsen,ScottD.;McDonald,WilliamG.;Gadwood,RobertC.;Kletzien,RolfF.;Zeller,JamesB.;Lee,PilH.;Adams,WadeJ.[BioorganicandMedicinalChemistry,2018,vol.26,#22,p.5870-5884]
[2]CurrentPatentAssignee:CIRIUSTHERAPEUTICS-WO2009/38681,2009,A1Locationinpatent:Page/Pagecolumn40
[3]CurrentPatentAssignee:METABOLICSOLUTIONSDEVELOPMENTCOMAPNY,LLC-WO2010/105048,2010,A1Locationinpatent:Page/Pagecolumn63-64
[4]CurrentPatentAssignee:CIRIUSTHERAPEUTICS-WO2014/93114,2014,A1Locationinpatent:Paragraph0399;0400
[5]CurrentPatentAssignee:CIRIUSTHERAPEUTICS-US9126959,2015,B2Locationinpatent:Page/Pagecolumn109
[1]CurrentPatentAssignee:CIRIUSTHERAPEUTICS-WO2011/133442,2011,A1Locationinpatent:Page/Pagecolumn33-34
[1]CurrentPatentAssignee:CIRIUSTHERAPEUTICS-WO2012/21476,2012,A1
[2]Tanis,StevenP.;Colca,JerryR.;Parker,TimothyT.;Artman,GeraldD.;Larsen,ScottD.;McDonald,WilliamG.;Gadwood,RobertC.;Kletzien,RolfF.;Zeller,JamesB.;Lee,PilH.;Adams,WadeJ.[BioorganicandMedicinalChemistry,2018,vol.26,#22,p.5870-5884]
[1]CurrentPatentAssignee:CIRIUSTHERAPEUTICS-WO2012/21476,2012,A1
[2]Tanis,StevenP.;Colca,JerryR.;Parker,TimothyT.;Artman,GeraldD.;Larsen,ScottD.;Gadwood,RobertC.;Zeller,JamesR.[TetrahedronLetters,2019,vol.60,#33]
[1]CurrentPatentAssignee:CIRIUSTHERAPEUTICS-WO2012/21476,2012,A1
Title: Chen Z, et al. Resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ-sparing thiazolidinedione. J Biol Chem. 2012 Jul 6;287(28):23537-48.
Title: Vigueira PA, et al. The beneficial metabolic effects of sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism. Exp Physiol. 2017 Aug 1;102(8):985-999.
